Clinical trial
Screening for Atrial Fibrillation in an Ambulatory Clinic Population: The VITAL-AF Study
NCT03515057 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Atrial Fibrillation in an Ambulatory Clinic Population: The VITAL-AF Study
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2018
- Completion date
- October 31, 2021
- Enrollment
- 35,308 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.